Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M Vannucchi, COMFORT-II InvestigatorsH.C. Kluin-Nelemans

    Research output: Contribution to journalArticleAcademicpeer-review

    116 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases

    Biochemistry, Genetics and Molecular Biology